Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Decuman

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|July 8, 2016
Disease activity indices in systemic sclerosis: a systematic literature reviewKarin Melsens, Filip De Keyser, Saskia Decuman, et al.
Work (Reading, Mass.)|August 1, 2022
IMBA-ICF linking by integrating consensus methods: How group consensus of experts can contribute to in-depth linking of instruments to the ICFStien Hennaert, Saskia Decuman, Huget Désiron, et al.
Plos One|January 12, 2019
Quickscan assesses risk factors of long-term sickness absence: A cross-sectional (factorial) construct validation studyKaat Goorts, Sofie Vandenbroeck, Tinne Vander Elst, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot studyVanessa Smith, Saskia Decuman, Alberto Sulli, et al.
Annals of the Rheumatic Diseases|March 24, 2016
Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohortValérie Lambrecht, Maurizio Cutolo, Filip De Keyser, et al.
Acta Clinica Belgica|April 15, 2016
The heart and pulmonary arterial hypertension in systemic sclerosisEls H Vandecasteele, Michel De Pauw, Guy Brusselle, et al.
The Journal of Rheumatology|November 3, 2012
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvementVanessa Smith, Yves Piette, Jens T van Praet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis developmentStijn Lambrecht, Vanessa Smith, Katelijne De Wilde, et al.
International Journal of Cardiology|April 9, 2016
Six-minute walk test in systemic sclerosis: A systematic review and meta-analysisEls Vandecasteele, Michel De Pauw, Filip De Keyser, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre studyVanessa Smith, Carmen Pizzorni, Filip De Keyser, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|July 8, 2016
Disease activity indices in systemic sclerosis: a systematic literature reviewKarin Melsens, Filip De Keyser, Saskia Decuman, et al.
Work (Reading, Mass.)|August 1, 2022
IMBA-ICF linking by integrating consensus methods: How group consensus of experts can contribute to in-depth linking of instruments to the ICFStien Hennaert, Saskia Decuman, Huget Désiron, et al.
Plos One|January 12, 2019
Quickscan assesses risk factors of long-term sickness absence: A cross-sectional (factorial) construct validation studyKaat Goorts, Sofie Vandenbroeck, Tinne Vander Elst, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot studyVanessa Smith, Saskia Decuman, Alberto Sulli, et al.
Annals of the Rheumatic Diseases|March 24, 2016
Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohortValérie Lambrecht, Maurizio Cutolo, Filip De Keyser, et al.
Acta Clinica Belgica|April 15, 2016
The heart and pulmonary arterial hypertension in systemic sclerosisEls H Vandecasteele, Michel De Pauw, Guy Brusselle, et al.
The Journal of Rheumatology|November 3, 2012
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvementVanessa Smith, Yves Piette, Jens T van Praet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis developmentStijn Lambrecht, Vanessa Smith, Katelijne De Wilde, et al.
International Journal of Cardiology|April 9, 2016
Six-minute walk test in systemic sclerosis: A systematic review and meta-analysisEls Vandecasteele, Michel De Pauw, Filip De Keyser, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre studyVanessa Smith, Carmen Pizzorni, Filip De Keyser, et al.
Pageof 4